Sign in
SLGL Stock Price, Chart, Stats & News
Sol-Gel Technologies Ltd.
Save
Sol-Gel Technologies Ltd. (SLGL) does not currently pay a dividend.
239.45M
Market cap
–
Current P/E
9.34x
Forward P/E
SLGL chart
Fundamentals
Gross margin | 99.44% |
Operating margin | -39.16% |
Pretax margin | -31.60% |
Net margin | -31.60% |
Effective tax rate | – |
ROA | -20.48% |
ROE | -24.29% |
D/E | 0.04x |
Interest coverage ratio | – |
SLGL valuation
P/E | – |
P/S | 11.48x |
P/B | 9.67x |
P/CF | – |
P/FCF | – |
P/OCF | – |
PEG | 0.63x |
EV multiple | 21.35x |
About
Sol-Gel Technologies Ltd., a pharmaceutical firm currently in its clinical development phase, specializes in the creation and market introduction of skin-applied medications. These products leverage the company's distinctive microencapsulation technology, with their primary development and commercialization activities centered in Israel. Sol-Gel's pipeline features several key candidates.
Similar securities
Based on sector and market capitalization
Report issue